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Effect of phenol-rich extra virgin olive oil on markers of
oxidation in healthy volunteers
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Objective: We studied whether consumption of phenol-rich extra virgin olive oil affects the susceptibility of low
density lipoproteins (LDL) to oxidation and other markers of oxidation in humans.
Design: Randomized cross-over intervention trial, stratified according to sex, age and energy intake.
Setting: Division of Human Nutrition and Epidemiology, Wageningen University, The Netherlands.
Subjects: Forty-six healthy men and women completed the study.
Intervention: Subjects consumed two diets supplying 69 g per day of extra virgin olive oil either rich or poor in
phenols for 3 weeks each. The mean difference in phenol intake between the treatments was 18 mg per day.
Vitamin E intake was low during the whole study. Fasting blood samples were taken twice at the end of each
period.
Results: Resistance of LDL and high density lipoprotein (HDL) to oxidation was not affected by treatment. The
mean lag time of copper-induced formation of conjugated dienes was 1.6 min shorter in LDL and 0.4 min longer in
HDL after the high phenol diet. Other markers of antioxidant capacity in plasma were also not affected: mean lipid
hydroperoxides were 0.07 mmol=l higher, mean malondialdehydes were 0.001 mmol=l higher, mean protein
carbonyls were 0.001 nmol=mg protein lower, and the mean ferric reducing ability of plasma (FRAP) was
0.006 mmol=l higher after the high phenol diet. All 95% confidence intervals enclosed zero. Serum cholesterol
concentrations were not affected by the treatment.
Conclusion: Consumption of 18 mg per day of phenols from extra virgin olive oil for 3 weeks did not affect LDL
or HDL oxidation or other markers of antioxidant capacity in fasting plasma samples.
Sponsorship: Supported by the International Olive Oil Council and the Foundation for Nutrition and Health
Research.
Descriptors: phenols; tyrosol; hydroxytyrosol; oleuropein; olive oil; antioxidants; LDL-oxidation; HDL-
oxidation; lipid hydroperoxides; malondialdehyde; protein carbonyls; FRAP
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Introduction
The Mediterranean diet, with olive oil as the major fat
source, has been shown in epidemiological studies to be
associated with a reduced incidence of coronary heart
disease (Keys et al, 1986). The replacement of dietary
saturated fatty acids with monounsaturated oleic acid from
olive oil decreases plasma LDL concentrations, which
presumably contributes to the low incidence of coronary
heart diseases (Katan et al, 1995). It has also been sug-
gested that a high-monounsaturated fat diet lowers the risk
of coronary heart disease by producing oleic acid-enriched
LDL particles, which are more resistant to oxidative
modification (Bonanome et al, 1992; Reaven et al, 1991;
Aviram & Eias, 1993). Oleic acid, however, may not be the
only component of olive oil protecting LDL from oxida-
tion; some types of extra virgin olive oil contain phenols
with antioxidative properties. These phenols are formed
during ripening of olives by hydrolysis of the parent
compound oleuropein (Figure 1), and they are, in contrast
to phenols from, for example tea and wine, partly lipid-
soluble.
The oxidative modification hypothesis of atherosclerosis
suggests that LDL particles are oxidatively modified and
then taken up by macrophages inside the arterial wall. Such
cholesterol-laden macrophages form the start of athero-
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sclerotic plaques. Dietary antioxidants may therefore inhi-
bit atherogenesis by inhibiting oxidation of LDL and
accumulation of LDL in macrophages (Witztum & Stein-
berg, 1991). When olive oil is ingested, the lipid-soluble
phenols are possibly taken up by LDL particles in plasma.
Thus, these phenols may protect LDL particles from
becoming atherogenic by oxidative modification. The aim
of this study was to determine whether consumption of
phenols from olive oil affects the susceptibility of LDL to
oxidation and other markers of oxidation in normolipemic
humans.
Subjects and methods
Subjects
Subjects were recruited via publicity in local newspapers
and posters in university buildings and student apartments.
We carefully explained the study protocol before subjects
gave their written informed consent. The study protocol
was approved by the Medical Ethical Committee of the
Division of Human Nutrition and Epidemiology of
Wageningen University.
Subjects were eligible if they were older than 17 y, did
not use any drugs known to affect concentrations of serum
lipids, were not pregnant, not lactating, and not on a
prescribed diet. Volunteers filled out a medical question-
naire that was reviewed by an independent physician.
Persons with a history of gastrointestinal, liver or kidney
disease were excluded, as were those with glucosuria,
proteinuria, anaemia, a serum concentration of total cho-
lesterol >7.0 mmol=l, or fasting triglycerides >2.3 mmol=l,
and serum values of liver enzymes >30 U=l for alanine
aminotransferase (ALT), or >30 U=l for aspartate amino-
transferase (AST). Thirty-two women and 17 men, 18 –
58 y, were enrolled in the study. Three subjects withdrew
during the study; one because of illness unrelated
to the treatment, and two because of personal reasons.
Figure 1 Structures of various phenols and their degradation into tyrosol and hydroxytyrosol in olives and extra virgin olive oil.
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Forty-six subjects completed the study. None of the sub-
jects used medications that could have affected the results.
Design and treatment
The study consisted of two 3-week treatment periods,
during which each subject consumed two diets, one with
phenol-rich extra virgin olive oil and one with phenol-poor
extra virgin olive oil, in random order (cross-over). Before
the study subjects were stratified according to sex, age and
energy intake and then randomly allocated to one of the
two sequence groups. During the 2 weeks before the study
(run-in) and 2 weeks in-between the treatment periods
(wash-out) subjects consumed diets without olives, olive
oil and olive oil products.
The high phenol olive oil was prepared from Tsunati
olives with a high content of phenols. The low phenol olive
oil was prepared from Koroneiki olives; most of the
phenols were removed by washing with hot water. Vitamin
E was added to the high phenol olive oil to obtain the same
vitamin E content in both oils. The two olive oils had a
similar fatty acid composition (data not shown). The phenol
concentration in the experimental oils was determined as
described by Montedoro et al (1993). The high phenol olive
oil contained 308 mg=kg of phenols, of which 2% was
tyrosol, 1% was hydroxytyrosol, 72% were oleuropein-
aglycones, and 25% were ligstroside-aglycones. The low
phenol olive oil contained 43 mg=kg of phenols, of which
16% was tyrosol, 2% was hydroxytyrosol, 13% were
oleuropein-aglycones, and 69% were ligstroside-aglycones.
The mean difference in phenol intake between the high and
low phenol diet was 18 mg=day.
Before the trial, energy intake of individual subjects was
estimated by a food frequency questionnaire (Feunekes et
al, 1993). Each subject received the amount of olive oil that
fulfilled energy needs. Energy intakes were subdivided into
four levels, ranging from 7.5 to 17.5 MJ per day. The
amount of olive oil per day varied from 55 to 102 g, with
a mean intake of 69 g. Forty percent of the daily oil was
incorporated into a mayonnaise (78 w=w% olive oil), 30%
was incorporated into sauces for hot meals, and 30% in
cookies and raisin rolls baked by a local bakery. We
recorded body weights twice weekly and adjusted the
intake of olive oil when necessary so as to maintain a
stable weight. Over the duration of the trial average body
weight increased by 0.3 0.9 kg (range ÿ1.2 – 2.8 kg).
Body weight did not differ between treatments; it was
68.0 9.6 kg on the high phenol diet, and 67.8 9.5 kg
on the low phenol diet.
Each study diet was assigned a colour code that was
used for labelling all foods supplied during the trial. In this
way, subjects were blinded to the type and the sequence of
the olive oils. On weekdays at noon, hot meals were served
and eaten at the department in the presence of the research-
ers. These meals supplied at least 50% of the experimental
olive oil. Foods that contained the remaining part of the
olive oil were consumed at home. Foods containing the
experimental olive oil were weighed or counted for each
subject. During the whole study subjects followed instruc-
tions for a background diet low in vitamin E. A margarine
with a low vitamin E content was supplied (Van den Bergh
Foods, UK). Apart from this, subjects were asked to
maintain their usual diet. During the study subjects were
not allowed to take vitamin supplements or aspirin, which
is a radical scavenger (Kuhn et al, 1995; Hermann et al,
1999). Therefore they were provided with acetaminophen
(paracetamol). Subjects were asked to maintain their usual
pattern of physical activity and not to change their smoking
habits, consumption of coffee, or use of oral contraceptives.
All subjects kept daily records of illness and deviations
from the protocol. Diaries and anonymous questionnaires
administered after the trial showed that consumption of
experimental olive oil was 90% of the scheduled amount
for the low phenol diet and 87% for the high phenol diet.
To check adherence, we added 6.8 mmol=g of lithium
chloride to the mayonnaise. The daily intake of lithium
was 190 – 360 mmol=day, depending on the level of energy
intake and consequently the amount of olive oil consumed
per day. Mean plasma lithium concentrations after olive oil
consumption was 4.7 1.3 mmol=l, which was about five
times the concentration of 0.9 0.3 mmol=l in similar sub-
jects that did not consume added lithium chloride (De Roos
et al, 2001). This confirmed adherence of the subjects to the
protocol.
Blood sampling
Venous blood samples were taken twice after a 12-h fast at
the end of each 3-week period (days 17 and 21). Plasma or
serum was immediately obtained by low speed centrifuga-
tion and stored at ÿ80C. For the determination of the
concentration of serum lipids, the liver enzymes, uric acid
and the ability of plasma to reduce iron (III) (FRAP), the
two samples of each subject at the end of each period were
analysed separately and the results were averaged before
statistical analysis. For the determination of the suscept-
ibility of LDL and HDL to oxidation, the two samples
obtained at the end of each period were pooled before
analytical analyses. For all other analyses, only the last
samples obtained at the end of each period were used.
Lipoprotein isolation
Plasma lipoproteins were isolated by density gradients
ultracentrifugation in a SW 41Ti rotor (Beckman Instru-
ments, Palo Alto, USA) for 24 h at 10C (Redgrave et al,
1975). LDL was isolated in a density range of 1.019 –
1.063 g=ml, and HDL in a density range of 1.063 –
1.210 g=ml. Density gradients solutions contained 0.1 mM
Na2EDTA to inhibit metal ion catalysed LDL and HDL
oxidation during the isolation procedure.
Markers of oxidizability
The susceptibility of LDL and HDL to copper-mediated
oxidation was determined by monitoring the formation of
conjugated dienes, essentially as described by Princen et al
(1992). Malondialdehyde in plasma was determined as
described by Wong et al (1987), except that the HPLC
eluent was monitored using fluorescence detection. The
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excitation wavelength was 537 nm and the emission wave-
length was 554 nm. Lipid hydroperoxides in plasma were
determined by the K-Assay LPO-CC kit (Kamiya Biome-
dical Company, Seattle, WA USA). Protein carbonyls in
plasma were determined by an ELISA method as described
by Buss et al (1997). The ability of plasma to reduce iron
(III) (FRAP) was determined by the method of Benzie and
Strain that measures the reduction of ferric to ferrous iron
in the presence of antioxidants (Benzie & Strain 1996).
Vitamin and uric acid concentrations in serum
The concentrations of lycopene, b-carotene, retinol and a-
tocopherol in serum samples were determined by high
performance liquid chromatography (HPLC, Waters Instru-
ments, Milfort, USA). Serum was deproteinised with
ethanol-internal standard solution (1:1 v=v) and extracted
with hexane. A part of the hexane layer was evaporated
after centrifugation and reconstituted in the mobile phase.
Samples to determine retinol and a-tocopherol were
injected into a Resolve C18-5 mm column (30 cm3.9 mm;
Waters Instruments, Milfort, USA) with methanol=
dichloromethane=acetonitrile (10:20:70, v=v) as the
mobile phase, with detection at 325 and 292 nm, respec-
tively. Samples to determine lycopene and b-carotene
were injected into a Sperisorb 5 mm ODS-2 column
(25 cm4.6 mm; Waters Instruments, Milfort, USA) with
methanol=dichloromethane=acetonitrile (30:20:50, v=v) as
the mobile phase, with detection at 472 and 450 nm,
respectively. Calibration was performed by a single stan-
dard solution on the same way as a sample. Serum uric acid
was determined by UA plus kit (Boehringer, Mann-
heim, Germany).
Serum lipids and liver enzymes
Serum lipids were analysed enzymatically (Siedel et al,
1983; Warnick et al, 1982; Fossati & Prencipe, 1982).
Mean bias for control samples provided by the Centers of
Disease Control in Atlanta was ÿ1% for total and high
density lipoprotein cholesterol and 10% for triglycerides.
The coefficient of variation within runs ranged from 0.5 to
1.1%. Low density lipoprotein cholesterol concentrations
were calculated (Friedewald et al, 1972). Alanine and
aspartate aminotransferase were measured at 37C using
Abbott Spectrum reagents (Bergmeyer et al, 1978). The
mean bias for ‘Monitrol’ control sera (Baxter Dade, Swit-
zerland) ranged from 0 to 2%. The coefficient of variation
within runs ranged from 2 to 8%.
Statistical analyses
The data were analysed by ANOVA using the General
Linear Models (GLM) of the Statistical Analyses System
(SAS Institute Inc., 1989). The Tukey method was used for
calculation of 95% confidence limits of the differences
between the two diets.
Results
Markers of oxidizability
Resistance of LDL and HDL to copper-mediated oxidation
and other markers of antioxidant capacity or oxidative
processes were not affected by treatment (Table 1). The
lag time of copper-induced formation of conjugated dienes
was 1.6 min shorter in LDL and 0.4 min longer in HDL
after the high phenol diet. Maximum rate of diene forma-
tion in LDL and HDL were similar after both treatments
(Table 1).
Other oxidation markers were also not affected. Plasma
lipid hydroperoxides and malondialdehydes, both markers
of lipid peroxidation, were respectively 0.07 and
0.001 mmol=l higher after the high phenol diet. Protein
carbonyls, a marker of protein oxidation in plasma, were
0.001 nmol=mg protein lower after the high phenol diet.
The ferric reducing ability of plasma (FRAP), a marker for
the antioxidant capacity of plasma, was 0.006 mmol=l
higher after the high phenol diet. All 95% confidence
intervals enclosed zero (Table 1).
Table 1 Oxidizability of LDL and HDL, and other oxidation markers at the end of the high and the low phenol diet
(n 46)
Differences between high
and low phenol diet
Low phenol diet High phenol diet (95% CI)
LDL oxidizabilitya
Lag time (min) 110.2 25.0 108.6 20.4 ÿ1.6 (ÿ8.2 – 5.0)
Maximum rate (nmol dienes=min=mg LDL protein) 12.0 2.6 11.8 2.3 ÿ0.1 (ÿ0.6 – 0.4)
HDL oxidizability
Lag time (min) 69.3 47.5 69.7 50.5 0.4 (ÿ12.8 – 13.5)
Maximum rate (nmol dienes=min=mg HDL protein) 4.6 2.2 4.4 2.2 ÿ0.1 (ÿ0.3 – 0.03)
Malondialdehyde (mmol=l) 0.68 0.15 0.69 0.13 0.001 (ÿ0.03 – 0.03)
Lipid hydroperoxides (mmol=l) 0.36 0.52 0.44 0.54 0.07 (ÿ0.07 – 0.21)
Protein carbonyls (nmol=mg protein) 0.23 0.12 0.23 0.12 ÿ0.001 (ÿ0.02 – 0.02)
Ferric reducing ability of plasma (mmol=l) 1.05 0.18 1.06 0.18 0.006 (ÿ0.01 – 0.02)
Values are means s.d. Participants (15 men and 31 women) consumed both diets in random order for 3 weeks each.
an 44.
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Vitamin and uric acid concentrations in serum
Serum uric acid, lycopene, retinol, b-carotene or a-toco-
pherol was not affected by the treatment (Table 2). The
concentration of a-tocopherol in our subjects was
19.4 5.0 mmol=l, which is relatively low compared to
normal plasma vitamin E concentrations from 11 to
37 mmol=l (Cohn, 1997). This can be explained by the
low vitamin E content in the diet. This suggested adherence
of the subjects to the protocol.
Serum lipids and liver enzymes
Mean total cholesterol was 0.06 mmol=l lower (not signifi-
cant) on the high phenol diet than on the low phenol diet.
Concentrations of LDL, HDL, triglycerides and the liver
enzymes alanine and aspartate aminotransferase also did
not differ between the high and low phenol diet (Table 3).
Discussion
Our data show that consumption of 18 mg per day of
phenols from olive oil for 3 weeks does not affect in
vitro susceptibility of LDL to oxidation or other markers
of oxidation in fasting blood of healthy volunteers.
Our results are in line with two other human studies that
addressed the effect of minor components in olive oil on
the susceptibility of LDL to oxidation in fasting blood
(Nicolaı¨ew et al, 1998; Bonanome et al, 2000). In these
studies, extra virgin olive oil vs high oleic acid sunflower
oil or refined olive oil also did not affect the in vitro
susceptibility of LDL to oxidation in fasting plasma sam-
ples. Other human studies on the effect of olive oil on LDL
oxidation addressed the effects of oleic acid rather than
olive oil phenols per se (Reaven et al, 1991; Bonanome
et al, 1992; Tsimikas et al, 1999). In vitro, the olive oil
phenols hydroxytyrosol and oleuropein strongly inhibited
LDL oxidation (Visioli et al, 1995; Visioli & Galli, 1994).
Also, tyrosol, oleuropein and extracts of minor components
from extra virgin olive oil decreased the oxidation of LDL
as assessed by oxysterol formation (Berra et al, 1995;
Caruso et al, 1999). We realise that LDL oxidation ex
vivo is different from LDL oxidation in vitro. Phenols or
antioxidants might get lost during isolation of LDL from
plasma by centrifugation, a process that is absent when
doing experiments in vitro. However, in rabbits and rats,
non-tocopherol antioxidants from olive oil showed a
favourable effect on the susceptibility of LDL to oxidation
(Wiseman et al, 1996; Coni et al, 2000; Scaccini et al,
1992). This suggests that during isolation phenols might
stay in or attached to lipoprotein particles where they might
affect the resistance of LDL to oxidation. Thus, results of
animal and in vitro studies suggest a protective effect of
phenols from olive oil on LDL oxidation, but such an effect
was not observed in fasting blood samples of humans in the
Table 3 Serum lipid and lipoprotein cholesterol concentrations at the end of the high and the low phenol diet (n 46)
Differences between high and
low phenol diet
Low phenol diet High phenol diet (95% CI)
Lipoproteins (mmol=l)
Total cholesterola 4.25 0.83 4.19 0.76 ÿ0.06 (ÿ0.15 – 0.04)
HDL cholesterola 1.54 0.36 1.52 0.37 ÿ0.01 (ÿ0.06 – 0.04)
LDL cholesterola 2.29 0.65 2.26 0.59 ÿ0.04 (ÿ0.12 – 0.05)
Triglyceridesb 0.92 0.35 0.90 0.32 ÿ0.02 (ÿ0.08 – 0.04)
Liver enzymes (U=l)
Alanine aminotransferase 20.3 7.0 20.7 7.7 0.3 (ÿ1.0 – 1.6)
Aspartate aminotransferase 21.7 4.7 21.8 5.1 0.1 (ÿ1.0 – 1.2)
Values are means s.d. Participants (15 men and 31 women) consumed both diets in random order for 3 weeks each.
aTo convert to mg=dl, multiply by 38.67.
bTo convert to mg=dl, multiply by 88.54.
Table 2 Serum concentration of uric acid, lycopene, b-carotene, retinol and a-tocopherol at the end of the high and the
low phenol diet (n 46)
Differences between high and
low phenol diet
Low phenol diet High phenol diet (95% CI)
Uric acid (mmol=l) 260.6 56.1 264.4 58.0 3.8 (ÿ2.2 – 9.8)
Lycopene (mmol=l)a 0.59 0.20 0.61 0.19 0.01 (ÿ0.05 – 0.08)
b-Carotene (mmol=l)a 0.54 0.23 0.52 0.24 ÿ0.02 (ÿ0.08 – 0.04)
Retinol (mmol=l)a 2.51 0.55 2.47 0.70 ÿ0.04 (ÿ0.2 – 0.1)
a-tocopherol (mmol=l) 19.77 4.58 18.97 5.37 ÿ0.8 (ÿ2.1 – 0.5)
Values are means s.d. Participants (15 men and 31 women) consumed both diets in random order for 3 weeks each.
an 40.
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present and other studies (Nicolaı¨ew et al, 1998; Bonanome
et al, 2000).
One explanation might be that our study did not address
postprandial effects. If phenol clearance is fast, phenol
concentrations might be elevated in the first hours after a
meal and during that time protect LDL from oxidation, but
not after 12 h of fasting as in our study. Visioli et al actually
found that the phenols tyrosol and hydroxytyrosol were
mostly excreted within 24 h after intake of 50 ml extra
virgin olive oil, which indicates that clearance of phenols
from plasma is fast (Visioli et al, 2000). Furthermore,
Bonanome et al found a significant postprandial effect 2 h
after intake of 100 g of extra virgin olive oil on plasma
antioxidant capacity, but they did not include a control
group (Bonanome et al, 2000). Nicolaı¨ew et al, on the other
hand, did not find a significant effect on the lag time or
maximum rate of LDL oxidation of extra virgin olive oil
6 h after intake (Nicolaı¨ew et al, 1998). The proper study of
postprandial effects requires more insight into the kinetics
of phenol transport and metabolism in man and more
studies are needed on this aspect.
We also did not find an effect of phenols from extra
virgin olive oil on the susceptibility of HDL to oxidation.
Like modified LDL, oxidatively modified HDL is sug-
gested to increase intracellular cholesterol accumulation
(Nagano et al, 1991; Gesquiere et al, 1997; Bonnefont-
Rousselot et al, 1995). The physiological role of HDL
oxidation is still unclear, but in our study 18 mg of phenols
per day for 3 weeks did not influence the susceptibility of
HDL to oxidation in fasting plasma samples.
Furthermore, we did not find an effect of olive oil
phenols on other plasma markers of lipid and protein
oxidation (lipid hydroperoxides, malondialdehyde, protein
carbonyls and FRAP). The average plasma values of the
oxidation markers in our study were in line with those
found in other studies. Lag time of LDL oxidation was
about 110 min, which is relatively high (Esterbauer &
Ju¨rgens, 1993). This can be explained by methodological
differences and the high dose of oleic acid that increases
the resistance of LDL to oxidative modification (Bonanome
et al, 1992; Reaven et al, 1991; Tsimikas et al, 1999).
Mean plasma lipid hydroperoxide and malondialdehyde
concentrations and FRAP were similar to values found by
others (Wong et al, 1987; Benzie & Strain, 1996). Protein
carbonyls were slightly higher in our subjects than in
healthy subjects in the study by Buss et al, but much
lower than in 23 critically ill subjects in the same study
(Buss et al, 1997). Thus, plasma values of the markers of
oxidation were within previously reported ranges.
The phenol oleuropein-aglycone and some of its deri-
vatives (Figure 1) from extra virgin olive oil are lipid-
soluble, while oleuropein, tyrosol and hydroxytyrosol are
water-soluble (Unilever Research Vlaardingen, unpub-
lished data). We therefore hypothesised that the lipid-
soluble aglycones, which are the main phenols in olive
oil, may accumulate in LDL and HDL particles and provide
better protection of LDL against oxidation than other, more
water-soluble, dietary compounds like phenols from tea and
wine, for example. The amount of phenols needed to
protect LDL and HDL from oxidation is unknown. Also,
data about the amounts of other antioxidants needed to
protect LDL from oxidation are scarce. Vitamin E is the
most important lipid-soluble antioxidant in the body (Prin-
cen et al, 1995; Jialal et al, 1995). In one dose – response
study Princen et al suggested that intake of 25 mg=day of
vitamin E for 2 weeks was sufficient to reduce the suscept-
ibility of LDL to oxidation (Princen et al,1995). In another
dose – response study, Jialal et al investigated the effects of
vitamin E intake in doses of 60, 200, 400, 800 and
1200 mg=day. They found that at least 400 mg=day of
vitamin E was needed to reduce the susceptibility of LDL
to oxidation (Jialal et al, 1995). Thus, the minimum dose of
vitamin E needed to reduce the susceptibility of LDL to
oxidation is as yet unclear. However, if 25 mg=day of
vitamin E is the minimum effective amount and if olive
oil phenols and vitamin E would be equally effective, then
the amount of 18 mg=day in our study might have been too
low to detect an effect on LDL oxidizability. Moreover,
vitamin E might partition better into LDL particles and thus
be more effective in reducing the susceptibility of LDL to
oxidation then phenols from olive oil. This implies that
even more dietary phenols would be needed to detect an
effect. Thus, the amount of 18 mg=day of olive oil phenols
in our study, a very high intake in terms of practical
realistic diets, might have been too low to affect LDL
oxidizability.
More is known about the in vitro than about the in vivo
antioxidant activity of olive oil phenols. In vitro dose –
response studies by Visioli and co-workers demonstrated
that pre-incubation of LDL with 10 mmol=l oleuropein or
10 mmol=l hydroxytyrosol inhibited the decrease of vitamin
E in LDL during copper-mediated oxidation and delayed
the formation of conjugated diene formation, lipid perox-
ides and thiobarbituric acid-reacting substances (Visioli et
al, 1995; Visioli & Galli, 1994). These studies showed that
the protection of vitamin E from oxidation was correlated
with the concentration of oleuropein or hydroxytyrosol, and
that a concentration of 1 mmol=l provided much less protec-
tion than a concentration of 10 mmol=l (Visioli et al, 1995;
Visioli & Galli, 1994). Visioli et al suggested that olive oil
phenols retard the oxidation of the natural vitamin E pool in
LDL and in this way indirectly protect LDL from oxida-
tion. We do not know the plasma concentration of the
various phenols that were reached in our study, but it is
unlikely that it reached 1 mmol=l after a whole-body dose of
18 mg (about 50 mmol) per day for 3 weeks. Thus, on the
basis of in vitro data the concentration of phenols in LDL
was probably too low to produce detectable effects on LDL
oxidizability.
It remains possible that amounts of olive oil phenols
higher than the 18 mg=day fed in our study can affect LDL
oxidizability. However, we supplied the maximum dose
that is achievable with practical every-day diets. Olives
were specially selected to obtain a large difference in
phenol concentration between the experimental oils, and
the subjects consumed large amounts of olive oil
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(69 g=day). The average daily intake of phenols from olive
oil is not exactly known, but estimations from the Medi-
terranean diet indicate that 10 – 20 mg=day of total phenols
may be supplied by olive oil (Visioli et al, 1995). Accord-
ing to our data, this is probably not enough to affect
markers of antioxidant status in fasting plasma samples.
It is conceivable that the background diet of our subjects
contained too high an amount of antioxidants to allow
additional antioxidant effects of the phenols of extra
virgin olive oil. Our subjects consumed a background diet
low in vitamin E, which was confirmed by the low plasma
vitamin E concentrations. Furthermore, subjects were not
allowed to take vitamin supplements. However, it is pos-
sible that tissue stores of vitamin C and vitamin E for
example, after the run-in period were still considerable, and
it may require depletion periods to show an effect. Thus,
olive oil might theoretically still affect oxidizability of
fasting LDL in subjects who are depleted in dietary anti-
oxidants.
The oxidative modification hypothesis of atherosclerosis
is an attractive one, but it is still not proven that dietary
antioxidants prevent coronary heart disease (Zock & Katan,
1998). Only a few studies have reported the relation
between markers of oxidation and coronary heart disease,
and the results of these studies are inconsistent (Van de
Vijver et al, 1998; de Rijke et al, 1995; Cominacini et al,
1993; Croft et al, 1992). Thus, none of the oxidation
markers have yet been validated as risk factors for athero-
sclerosis, although it may be that markers more represen-
tative of in vivo changes, like oxidised LDL antibodies,
may be more sensitive to changes in LDL antioxidant
content. Much work remains to be done here. In addition,
randomised clinical trials with hard endpoints are needed to
prove that dietary antioxidants, such as the phenols from
olive oils, may offer protection against coronary heart
disease.
The serum concentrations of total and LDL cholesterol
did not differ between the two diets. It has been suggested
that minor components, such as phenols, may be respon-
sible for a cholesterol-lowering effect (Matsumoto et al,
1998). We therefore studied the effects of olive oil phenols
on serum cholesterol concentrations. Our results are in line
with those of Nicolaı¨ew et al, who found that a diet with
extra virgin olive oil and a diet with oleic-acid-rich sun-
flower oil produced the same cholesterol concentrations
(Nicolaı¨ew et al, 1998). Thus, the cholesterol-lowering
effect of olive oil is probably not due to its phenolic
compounds.
We also measured the liver enzymes alanine amino-
transferase (ALT) and aspartate aminotransferase (AST).
Phenols from extra virgin olive oil are responsible for the
bitter taste of extra virgin olive oil. This bitter taste might
be a warning from nature for possible adverse or toxic
effects. We therefore measured ALT and AST as indicators
of such effects. In our study the serum concentrations of
ALT and AST did not differ between the two diets. This
suggests that phenols from olive oil have no adverse affects
on liver integrity.
In conclusion, we did not find an effect of a high intake
of phenol-rich olive oil on the susceptibility of LDL and
HDL to oxidation and other markers of oxidation in fasting
plasma. The natural concentration of phenols in olive oil
might be too low or their clearance from plasma too fast to
produce an effect on markers of oxidation in the post-
absorptive phase.
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